Exagen helps pharmaceutical companies advance their business and scientific objectives for clinical trials through rapid identification, development and licensing of small, optimized combinations of markers in support of pharmaceutical R&D or clinical trials.

We work with our Pharmaceutical partners to make sure that the diagnostic assay developed works effectively with a therapeutic to increase its effectiveness with patients and is in a laboratory format that is easy to transfer for broad accessibility.

For more information about Exagen's capabilities in this area, please contact: BusinessDevelopment@exagen.com 866.392.4361